COMMUNIQUÉS West-GlobeNewswire

« Le Canada comme chef de file » : Une nouvelle recherche de la CSMC sur le cannabis indique la voie à suivre
30/07/2019
OTTAWA, 30 juill. 2019 (GLOBE NEWSWIRE) -- De Commission de la santé mentale du Canada En collaboration avec l’Université de Calgary, la Commission de la santé mentale du Canada (CSMC) publie aujourd’hui un important [...]
Inventiva - H1 2019 Financial Information and Corporate Business Update
30/07/2019
H1 2019 1 Financial Information and Corporate Business Update Cash and cash equivalents of €37.1m as at June 30, 2019, in line with expectations H1 revenues at €1.2m Significant progress in NASH program, notably in the [...]
Inventiva - Information financière du 1er semestre 2019 et point sur l’activité
30/07/2019
Information financière du 1 er semestre 2019 1 et point sur l’activité Trésorerie et équivalents de trésorerie à 37,1 M€ au 30 juin 2019, conformément aux prévisions Chiffre d’affaires du semestre de 1,2 M€ Progrès [...]
SoldierStrong, Department of Veterans Affairs Partner to Treat Post-Traumatic Stress With Virtual Reality Systems
30/07/2019
STAMFORD, Conn., July 30, 2019 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing advanced medical technologies to veterans, and the Department of Veterans Affairs have signed a [...]
Ziopharm Oncology to Host Conference Call to Discuss Second Quarter 2019 Results on August 8, 2019
30/07/2019
BOSTON, July 30, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that management will host a conference call and webcast on Thursday, August 8, at 8:30 a.m. ET to provide a corporate [...]
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2019
30/07/2019
SALT LAKE CITY, July 30, 2019 (GLOBE NEWSWIRE) -- In the second calendar quarter (2Q) and first half (1H) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results which reflect that the Company remains on [...]
RESPIRERX PHARMACEUTICALS INC. SEND NOTICE LETTER TO THE BOARD OF DIRECTORS OF THERAPIX BIOSCIENCES LTD.
30/07/2019
Glen Rock, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the research and development of cannabinoids for the treatment of sleep-related [...]
AXIM® Biotechnologies Launches AXIM® Wellness Division Focused on Cannabinoid-Based Nutraceutical Products and Announces New Product Pipeline
30/07/2019
NEW YORK, July 30, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it [...]
HealthEquity and WageWorks Announce HSR Clearance
30/07/2019
DRAPER, Utah and SAN MATEO, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”) and WageWorks, Inc., (NYSE: WAGE) (“WageWorks”) today announced that they have received [...]
Oncotelic’s Patented Lead Anti-Cancer Drug Candidate as Well as Drug Delivery Platform for Brain Tumors on Track for Advanced Pivotal Phase 3 Clinical Testing
30/07/2019
AGOURA HILLS, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Oncotelic Inc. (“Oncotelic”), a wholly owned subsidiary of Mateon Therapeutics Inc. (OTCQB:MATN) dedicated to the development of innovative treatments for cancer, [...]
Emerald Health Therapeutics nomme un Président-directeur général
30/07/2019
Riaz Bandali a piloté l'innovation, les ventes et la rentabilité dans un certain nombre d'entreprises mondiales du secteur des sciences de la vie. Emerald nomme également un directeur commercial VICTORIA (Colombie- [...]
Tetra's Officers and Employees Participate in Private Placement
30/07/2019
ORLEANS, Ontario, July 30, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation”) is pleased to announce that, after successfully completing a prospectus offering for aggregate gross proceeds of $ [...]
Auris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute Vertigo
30/07/2019
Hamilton, Bermuda, July 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]
TransMedics Announces Successful Long Distance Retrieval and Transplantation of Donor Lungs from Hawaii Using Organ Care System (OCS™)
30/07/2019
ANDOVER, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, [...]
NewLink Genetics Provides Corporate Update and Reports Second Quarter 2019 Financial Results
30/07/2019
Announces management transition; Charles J. Link Jr, M.D. to retire as CEO and Chairman of the Board AMES, Iowa, July 30, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) (“NewLink Genetics” or the “ [...]
Fluidigm Announces 3rd Annual Imaging Mass Cytometry User Group Meeting
30/07/2019
Fluidigm Invites Researchers to the Largest Global Imaging Mass Cytometry Conference in Zurich, Switzerland SOUTH SAN FRANCISCO, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an [...]
LHC Group announces agreement to purchase assets from VNA Home Health of Maryland
30/07/2019
Purchase to include home health and home and community based services in Baltimore LAFAYETTE, La., July 30, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that it has agreed to purchase a home [...]
Eton Pharmaceuticals to Report Second Quarter 2019 Financial Results on Tuesday, August 6, 2019
30/07/2019
DEER PARK, Ill., July 30, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it [...]
Principia Announces Update to Ongoing Phase 2 Clinical Trial in Patients with ITP
30/07/2019
SOUTH SAN FRANCISCO, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]

Pages